X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

New Jersey Follows New York’s Lead In Limiting Construction To “Essential” Projects

Earlier this week, on Monday, we had reported that New Jersey was allowing, subject to proper distan...

Read More >

Fifth Circuit Affirms “My Disability Made Me Do It” Is No Excuse For Sleeping On The Job

Clark v. Champion National Security, Incorporated (No. 18-11613, January 14, 2020) is the Fifth Circ...

Read More >

IRS Finalizes Changes to 401(k) Hardship Distribution Rules

The Internal Revenue Service issued final regulations on September 19, 2019, easing the 401(k) hards...

Read More >

Employers and Coronavirus: A Brief Guide

The circumstances surrounding COVID-19 (commonly referred to as the “coronavirus”) are unfolding e...

Read More >

October Brings Increased Legal Exposure for Maryland Employers for Workplace Harassment Claims

Seyfarth Synopsis: Maryland has expanded employer liability for workplace harassment this week. Leg...

Read More >

California’s AB-5 Implications (Part 1)

“Some day, California’s going to fall into the ocean” usually refers to the San Andreas fault. No...

Read More >